Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US HurdlesZacks Investment Research • 08/06/25
Law Offices of Howard G. Smith Encourages Novo Nordisk A/S (NVO) Investors To Inquire About Securities Fraud Class ActionBusiness Wire • 08/06/25
Law Offices of Frank R. Cruz Encourages Novo Nordisk A/S (NVO) Investors To Inquire About Securities Fraud Class ActionBusiness Wire • 08/06/25
Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure WegovyInvestors Business Daily • 08/06/25
Novo Nordisk: Is there life after slow death for slimmed down drug maker?Proactive Investors • 08/06/25
Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025GlobeNewsWire • 08/06/25
Investor Alert: Robbins LLP Informs Investors of the Novo Nordisk A/S Class Action LawsuitGlobeNewsWire • 08/06/25
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights – NVOGlobeNewsWire • 08/05/25
Berger Montague PC Announces Class Action Filed Against Novo Nordisk A/S (NYSE: NVO) for Alleged Securities ViolationsPRNewsWire • 08/05/25
Rosen Law Firm Urges Novo Nordisk A/S (NYSE: NVO) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire • 08/05/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVOGlobeNewsWire • 08/05/25